TerminatedNot applicableNCT01782027
Mendelian Reverse Cholesterol Transport Study
Studying Hypoalphalipoproteinemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pennsylvania
- Principal Investigator
- Marina Cuchel, MD, PhDUniversity of Pennsylvania
- Intervention
- 3H-cholesterol bound to albumin(drug)
- Enrollment
- 17 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2012 – 2024
Study locations (1)
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01782027 on ClinicalTrials.gov